Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Florida International Developing Screening Methods for Designer Drugs

NEW YORK (GenomeWeb News) – Agilent Technologies today announced a collaboration with Florida International University to develop methods for the identification and characterization of designer drugs.

Agilent is working with FIU's department of chemistry and biochemistry and its International Forensics Research Institute and is currently focused on developing and validating methods for rapid forensic screening and analysis to expand the capabilities of drug screening techniques using immunoassays, the company said.

The collaboration will develop methods based on advanced chromatography and mass spectrometry systems, including LC-QQQ-MS/MS, LC-QTOF-MS, GC-MS, and GC-MS/MS.

Routine immunoassay drug-screening techniques cannot detect most of the hundreds of designer drugs, and FIU and Agilent seek to create new analytical methods to screen and confirm the presence of such drugs in ante- and post-mortem specimens, Anthony DeCaprio, associate professor and director of the Forensic & Analytical Toxicology facility at the university, said.

He added that he and his colleagues recently validated a technique for detecting and quantifying 32 drugs in serum, including 24 phenethylamines, four piperazines, and four tryptamines. With Agilent, they hope to expand their tandem mass spectral library to about 300 designer drugs.

Financial and other terms of the deal were not disclosed.

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.